110 results
Page 3 of 6
8-K
EX-1.1
ou6cvvt71gf24omug0
6 Aug 21
Entry into a Material Definitive Agreement
4:09pm
8-K
EX-10.3
9zd86en qcw
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
8-K
EX-10.1
e1znrsvawa
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
8-K
EX-10.2
xisztr8l2osxgfja
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
S-8
t7tk56n nnqoa
1 Mar 21
Registration of securities for employees
12:00am
S-8
EX-5.1
duw640ggppjn1a0 6y
1 Mar 21
Registration of securities for employees
12:00am
8-K
EX-1.1
0pya4suxrzteczi7hnp
18 Dec 20
Arvinas, Inc. Announces Pricing of $400 Million Public Offering of Common Stock
6:30am
424B5
2v8bh2 ies820b
16 Dec 20
Prospectus supplement for primary offering
4:01pm
424B5
1y31nyqumgzr5f7
14 Dec 20
Prospectus supplement for primary offering
4:48pm
S-3ASR
EX-4.8
a00vp cx4
14 Dec 20
Automatic shelf registration
4:02pm
S-3ASR
EX-4.5
js9imgahss0be
14 Dec 20
Automatic shelf registration
4:02pm
S-3ASR
EX-4.7
sjir815d qoppd
14 Dec 20
Automatic shelf registration
4:02pm
S-3ASR
wq61errtlzung7vgq80y
14 Dec 20
Automatic shelf registration
4:02pm
S-3ASR
EX-4.6
fa6wu 5oqxqzb
14 Dec 20
Automatic shelf registration
4:02pm